Calamos Advisors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-36,900
Closed -$7.19M 1189
2026
Q1
$7.19M Sell
36,900
-8,400
-19% -$1.37M 0.03% 479
2025
Q4
$12.7M Buy
+45,300
New +$10.8M 0.05% 347
2021
Q2
Sell
-150,000
Closed -$10.5M 994
2021
Q1
$10.5M Buy
+150,000
New +$9.71M 0.06% 324
2017
Q3
Sell
-324,300
Closed -$16.3M 645
2017
Q2
$16.3M Buy
+324,300
New +$14.8M 0.12% 224
2015
Q4
Sell
-2,500
Closed -$373K 679
2015
Q3
$373K Buy
+2,500
New +$96.1K ﹤0.01% 616

Other funds holding ORCL

Calamos Advisors's ORCL Position: Q2 2026 in Review

Calamos Advisors increased its Oracle (ORCL) stake by 4% in Q2 2026, buying an estimated $3.04M and bringing the position to 432,846 shares worth $63.4M. The position accounts for 0.21% of the portfolio, ranked #103.

Calamos Advisors first reported a position in ORCL in Q2 2013 and has held it in 53 quarters since. The position peaked at $182M in Q3 2025. 3,519 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Calamos Advisors held 432,846 shares of Oracle worth $63.4M as of Q2 2026.
  • Calamos Advisors bought 16,765 Oracle shares in Q2 2026, an estimated $3.04M.
  • Oracle made up 0.21% of Calamos Advisors's portfolio in Q2 2026, its #103 holding.
  • Calamos Advisors first reported a position in Oracle in Q2 2013 and has held it in 53 quarters since.
  • Calamos Advisors's Oracle position peaked at $182M in Q3 2025.
  • 3,519 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.